Skip to content
  • Home
  • contact-rita@ern-net.eu
  • News & Events
  • MeRITA Registry
  • FAQ
  • Contact
  • Facebook
  • LinkedIn
  • Twitter
ERN-RITA

ERN-RITA

European Reference Network for Immunodeficiency, Autoinflammatory, Autimmune and Pediatric Rheumatic disea

The European Reference Network that aims at improving the care of patients with Rare Immunological Disorders
  • Reference centers
  • Disease information
  • Virtual consultations
  • Activities
    • MeRITA Registry
    • Webinars
    • Working Groups
  • Patients
    • ERNs and ePAGs
    • RIPAG
  • About
    • RITA: A Unique Opportunity
    • Mission, Goals and Objectives
    • Governance
    • RITA Membership
    • Scientific societies, stakeholders
    • About ERNS
    • Monitoring
  • Rare diseases
  • Autoinflammatory disorders (AID)
  • Non inflammasome-related conditions
  • Recurrent idiopathic pericarditis
Rare diseases
    • Pediatric Rheumatic diseases (PR)
      • Juvenile Arthritis
      • Miscellaneous
      • Systemic autoimmune disease
      • Bone disease
      • Paediatric vasculitis
    • Autoimmune diseases (AI)
      • Autoimmune systemic vasculitis adult and paediatric
      • Autoimmune Neuroinflammation Adult and Paediatric
    • Autoinflammatory disorders (AID)
      • Defects affecting the inflammasome
      • Non inflammasome-related conditions
      • Type 1 Interferonopathies
      • Monogenic Inflammatory bowel diseases
      • Miscellaneous
    • Primary immunodeficiencies (PID)
      • Predisposition to invasive fungal diseases
      • Severe reduction in serum IgG and IgA with normal/elevated IgM and normal numbers of B cells
      • Chronic mucocutaneous candidiasis (CMC)
      • T−B+ Severe Combined Immunodeficiency (SCID)
      • Isotype or light chain deficiencies with generally normal numbers of B cells
      • TLR signaling pathway deficiency
      • T−B− SCID DNA recombination defects
      • Familial hemophagocytic lymphohistiocytosis (FHL) syndromes without hypopigmentation
      • Combined immunodeficiencies generally less profound than severe combined immunodeficiency
      • Familial hemophagocytic lymphohistiocytosis (FHL) syndromes with hypopigmentation
      • Congenital thrombocytopenia
      • T regulatory cells genetic defects
      • DNA repair defects (other than those in group 1)
      • Autoimmunity with or without lymphoproliferation
      • Thymic defects with additional congenital anomalies
      • Autoimmune lymphoproliferative syndrome (ALPS)
      • Immune-osseous dysplasias
      • Immune dysregulation with colitis
      • Hyper-IgE syndromes (HIES)
      • Type 1 Interferonopathies
      • Dyskeratosis congenita (DKC) with bone marrow failure and dysfunctional telomere maintenance
      • Congenital neutropenias
      • Defects of Vitamin B12 and Folate metabolism
      • Defects of Motility
      • Anhidrotic ectodermaldysplasia with immunodeficiency (EDA-ID)
      • Defects of Respiratory Burst
      • Calcium channel defects
      • Medelian Susceptibility to mycobacterial disease (MSMD)
      • Other defects
      • Epidermodysplasia verruciformis
      • Severe reduction in all serum immunoglobulin isotypes with profoundly decreased or absent B cells
      • Predisposition to severe viral infection
      • Severe reduction in at least 2 serum immunoglobulin isotypes with normal or low number of B cells
      • Herpes simplex encephalitis (HSE)

Recurrent idiopathic pericarditis

Orphacode: 251307

Disease information Hide
LinksFor clinicians and scientistsFor patients
Patient organisations Show
LinksHAE Junior
→ Access the newsletter archive

Scientific societies & Patient organisations

Network coordination

UMC Utrecht
Heidelberglaan 100
3584 CX Utrecht
Netherlands
VAT NL004205315B01

Follow us & get in touch:

 

The contents of this webpage are the sole responsibility of ERN-RITA and do not necessarily reflect the opinion of the European Union. 

© 2021 ERN RITA. All rights reserved. The RITA logo was designed by Luis Bordalo.